跳至主要内容
临床试验/ITMCTR2200005697
ITMCTR2200005697尚未招募1 期

Clinical study of acupoint application suitable for disease and syndrome

Affiliated Hospital of Shandong University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Meet the western diagnostic criteria for essential hypertension (Grade 1);
  • 2. Aged between 18 and 75 (including 18 and 75);
  • 3. Patients with essential hypertension (Grade 1) determined by hypertension blood pressure level should meet any one of the following three criteria:
  • (1) systolic blood pressure of 140 ~ 159 mmHg and/or diastolic blood pressure of 90 ~ 99mmHg, without taking any antihypertensive drugs in the past, no complications such as heart, brain and kidney;
  • (2) Patients who have been clearly diagnosed as essential hypertension and whose blood pressure is still below the standard of 140-159/90-99mmHg after 3 months of lifestyle improvement or other forms of non-drug treatment;
  • (3) Those who have been clearly diagnosed as essential hypertension and whose blood pressure has not reached the standard after improving lifestyle or other forms of non-drug therapy and taking oral antihypertensive drugs for 3 months, and who refuse to take other western antihypertensive drugs;
  • 4. The course of the patient clearly diagnosed as essential hypertension must be longer than 3 months;
  • 5. Those who voluntarily participate in clinical observation and sign informed consent.

排除标准

  • 1. Various secondary hypertension (renal essential hypertension, nephrovascular hypertension, primary aldosteronism, pheochromocytoma, cortisolism, aortic coarctation, etc.);
  • 2. Have accepted other new drug clinical experimenter in recent 3 months;
  • 3. Patients with serious diabetic complications (diabetic retinopathy, diabetic nephropathy, diabetic peripheral neuropathy, diabetic foot, etc.) or patients with myocardial infarction or history of stroke within six months;
  • 4. Pregnant or trying to get pregnant and breast-feeding women;
  • 5. People who have been allergic to multiple drugs or have an allergic constitution;
  • 6. Persons with combined mental illness, alcoholism and/or psychoactive substance substance abuse and dependence;
  • 7. Simultaneous combination of the following organ damage or disease: Angina pectoris, heart failure, transient cerebral insufficiency, hypertensive encephalopathy, retinopathy (with or without optic papilledema), renal failure with plasma creatinine concentration above 2.0mg/dl, liver failure, aortic dissection or aortic aneurysm, Patients with obvious symptoms of arterial occlusive diseases, malignant tumors, diseases of hematopoietic system, gastrointestinal ulcer bleeding and bleeding tendency.
  • 8. Patients with skin trauma, ulcers, skin infection or scar at the application site and those who are allergic to the patch.
  • Note: any one or more of the above items should be excluded and cannot be selected.

研究者

发起方
Affiliated Hospital of Shandong University of Traditional Chinese Medicine

相似试验

Randomized, double-blind, placebo-controlled,... | 临床试验